You are here: Industry Insights > COVID-19 vaccine

News List

Sanofi to manufacture Moderna’s Covid-19 vaccine in the US pharmaceutical-technology
April 28, 2021
Sanofi has entered an agreement to manufacture up to 200 million doses of Moderna’s Covid-19 vaccine in the US.
Brazil’s Anvisa rejects import of Russia’s Covid-19 vaccine pharmaceutical-technology
April 28, 2021
The Brazilian National Health Surveillance Agency (Anvisa) has rejected the import of the Russian Covid-19 vaccine, Sputnik V, citing a lack of consistent and reliable data.
Israel assesses myocarditis cases linked to Pfizer-BioNTech Covid-19 vaccine pharmaceutical-technology
April 27, 2021
The Israel Health Ministry is examining a small number of cases related to inflammation of the heart muscle called ‘myocarditis’ in individuals inoculated with Pfizer and BioNtech’s Covid-19 vaccine.
Health Canada to review rolling submission for Medicago’s Covid-19 vaccine pharmaceutical-technology
April 27, 2021
Health Canada has accepted for review the first portion of the rolling submission by Medicago for its plant-derived adjuvanted Covid-19 vaccine candidate.
Inactivated COVID-19 vaccine candidate enters comparative immunogenicity trial europeanpharmaceuticalreview
April 26, 2021
The Phase III trial aims to demonstrate that Valneva’s VLA2001 is more immunogenic than AstraZeneca’s conditionally approved COVID-19 vaccine, Vaxzevria.
CureVac Swiss AG initiates rolling submission process for mRNA-based COVID-19 vaccine candidate, CVnCoV, with Swissmedic worldpharmanews
April 26, 2021
The CureVac Swiss AG, the Swiss subsidiary of CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced initiation of a rolling submission for CVnCoV ...
INOVIO Planning for ex-US Global Phase 3 Trial for INO-4800 prnasia
April 25, 2021
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, announced that it is planning for a predominantly ex-U.S. Phase 3 ...
J&J COVID-19 vaccine may be imported by July expresspharma
April 25, 2021
India has said it would fast-track emergency approvals for COVID-19 vaccines authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson and Moderna shots.
Cadila Healthcare initiates production of ZyCoV-D expresspharma
April 25, 2021
Cadila Healthcare has started producing its potential COVID-19 vaccine for which it will seek emergency use authorisation in May or June, its managing director told Reuters, with an aim to make up to 240 million doses a year.
Inovio may move COVID-19 vaccine trial overseas after funding from US ends expresspharma
April 25, 2021
Inovio said, depending on the results of its mid-stage trial, it would run the late-stage study for its vaccine candidate, INO-4800, with partners such as China’s Advaccine and the International Vaccine Institute.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page